<DOC>
	<DOCNO>NCT00132821</DOCNO>
	<brief_summary>Smoking major health problem direct link elevate heart- lung-related problem . Nicotine highly addictive , make quit difficult relapse quit highly probable . Any type sleep disturbance may make quit even hard . The purpose study evaluate effect bupropion nicotine replacement therapy ( NRT ) sleep disturbance . In turn , might show medication affect attempt smoke cessation .</brief_summary>
	<brief_title>Impact Smoking Cessation Sleep - 5</brief_title>
	<detailed_description>The majority attempt quit smoke end failure due unpleasant withdrawal symptom . One symptom sleep disturbance . Bupropion , effective assist smoke cessation , commonly cause sleep disturbance medication side effect . In addition , number NRTs also cause sleep disturbance . This study aim characterize effect smoke cessation smoking cessation treatment sleep measure central autonomic nervous system arousal . The study also evaluate impact smoke cessation treatment daytime sleepiness mood well effect smoke relapse . Participants randomly assign one four group . Participants receive either bupropion ( 150 mg 3 day 300 mg 60 day ) placebo , start one week prior smoke quit day . They receive either active NRT ( 21 mg 6 week , 14 mg 1 week , 7 mg 1 week ) placebo , start quit day . Participants study 5 night sleep lab . Sleep study include polysomnography measurement , include electrooculography eye , activity mentalis muscle anterior tibialis muscle , EEG , ECG , oxygen saturation , airflow , respiratory effort . Sleep study occur 2 night prior quit day , quit night , 2 night quit . Each sleep study follow daytime measure . These include series self-report instrument , sleepiness performance measure , physiological activity measure . Carbon monoxide level also daytime measurement must fall 10 ppm post quit day . All participant receive bimonthly phone counsel 12 month , start quit day . Participants follow-up evaluation Months 3 12 order measure carbon monoxide level complete self-report instrument .</detailed_description>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Meets DSMIV criterion nicotine dependence History smoking least 20 cigarette day 2 year prior enrollment Expired carbon monoxide level least 10 ppm Body mass index less 30 kg/m2 Meets DSMIV criterion dependence substance nicotine caffeine Substance abuse within year prior enrollment History DSMIV diagnosis schizophrenia , bipolar disorder , obsessive compulsive disorder , chronic depression Current diagnosis major depression History neurological illness trauma ( e.g. , stroke , seizure disorder , febrile seizure , electroconvulsive therapy ) Family history seizure disorder History head injury loss consciousness longer 1 hour Currently diagnose sleep disorder Currently diagnose anorexia bulimia Severe chronic cardiovascular , lung , kidney , neurological disease Uncontrolled hypertension diabetes Use medication contraindicate bupropion High frequency alcohol use binge drink month prior enrollment Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Nicotine dependence</keyword>
	<keyword>Sleep disorder</keyword>
	<keyword>smoke cessation</keyword>
	<keyword>Relapse</keyword>
</DOC>